| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 大容量注射液(元) | 3,749,975,809.00 | 8,911,678,039.00 | 4,667,301,102.00 | 10,109,201,289.00 | 5,026,896,181.00 |
| 非大容量注射液(元) | 4,393,945,959.00 | 10,300,327,368.00 | 5,408,989,284.00 | 9,056,854,750.00 | 4,296,867,540.00 |
| 研发项目(元) | 636,852,225.00 | 1,894,758,860.00 | 1,386,877,475.00 | 1,548,237,291.00 | 1,043,182,061.00 |
| 其他(元) | - | - | - | - | 366,980,827.00 |
| 营业成本(元) | |||||
| 大容量注射液(元) | 1,646,881,953.00 | 3,550,566,794.00 | 1,761,148,485.00 | 3,640,646,003.00 | 1,799,083,378.00 |
| 非大容量注射液(元) | 2,396,437,408.00 | 5,777,822,294.00 | 3,121,061,955.00 | 5,280,811,074.00 | 2,585,874,661.00 |
| 研发项目(元) | 273,144,978.00 | 653,752,620.00 | 304,183,878.00 | 748,819,711.00 | 337,202,865.00 |
| 其他(元) | - | - | - | - | 292,842,502.00 |
| 毛利(元) | |||||
| 大容量注射液(元) | 2,103,093,856.00 | 5,361,111,245.00 | 2,906,152,617.00 | 6,468,555,286.00 | 3,227,812,803.00 |
| 非大容量注射液(元) | 1,997,508,551.00 | 4,522,505,074.00 | 2,287,927,329.00 | 3,776,043,676.00 | 1,710,992,879.00 |
| 研发项目(元) | 363,707,247.00 | 1,241,006,240.00 | 1,082,693,597.00 | 799,417,580.00 | 705,979,196.00 |
| 其他(元) | - | - | - | - | 74,138,325.00 |
| 毛利率(%) | |||||
| 大容量注射液(%) | 56.08 | 60.16 | 62.27 | 63.99 | 64.21 |
| 非大容量注射液(%) | 45.46 | 43.91 | 42.30 | 41.69 | 39.82 |
| 研发项目(%) | 57.11 | 65.50 | 78.07 | 51.63 | 67.68 |
| 其他(%) | - | - | - | - | 20.20 |
| 收入构成(%) | |||||
| 大容量注射液(%) | 42.71 | 42.22 | 40.72 | 48.80 | 46.83 |
| 非大容量注射液(%) | 50.04 | 48.80 | 47.19 | 43.72 | 40.03 |
| 研发项目(%) | 7.25 | 8.98 | 12.10 | 7.47 | 9.72 |
| 其他(%) | - | - | - | - | 3.42 |
| 毛利构成(%) | |||||
| 大容量注射液(%) | 47.11 | 48.19 | 46.30 | 58.57 | 56.44 |
| 非大容量注射液(%) | 44.74 | 40.65 | 36.45 | 34.19 | 29.92 |
| 研发项目(%) | 8.15 | 11.16 | 17.25 | 7.24 | 12.34 |
| 其他(%) | - | - | - | - | 1.30 |